EUVIMEDEUVIMED entdecken
Crossref

In silico Identification of Phytochemical Inhibitors targeting 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase (FabG4) in Mycobacterium tuberculosis

Jagriti Singh, Vinny Virdi, Rolee Sharma, Dipesh Kumar Verma

Research Journal of Biotechnology · 30.04.2026 · 6 (21) · 89

DOI: 10.25303/216rjbt0890102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research Journal of Biotechnology, online erschienen am 30.04.2026. Verfasst von Jagriti Singh und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a major global health challenge, further complicated by the rise of drugresistant strains. Targeting essential enzymes involved in Mtb survival pathways offers a promising strategy for developing novel therapeutics. One such enzyme is 3-oxoacyl-(acyl-carrier-protein) reductase (FabG4), a key component of the fatty acid synthesis pathway critical for maintaining Mtb cell wall integrity. In this study, we employed in silico molecular docking and molecular dynamics simulations to identify potential phytochemical inhibitors of FabG4. A library of 46 phytochemicals was screened based on their binding affinities and pharmacokinetic properties. Compounds demonstrating strong binding energies and favorable interaction profiles were prioritized for further analysis. Detailed interaction studies revealed the formation of significant hydrogen bonds, hydrophobic interactions and van der Waals forces between the phytochemicals and key residues within the FabG4 active site. Among the screened molecules, apohyosine (-9.11 kcal/mol), cinannamnol (-8.53 kcal/mol), savitol (-8.07 kcal/mol) and obtusifolin (-7.41 kcal/mol) exhibited notable binding affinities along with acceptable pharmacokinetic characteristics, highlighting their potential as lead compounds. Overall, this study underscores the potential of phytochemicals as a valuable resource for the development of FabG4- targeted anti-TB agents. The findings provide insights into critical molecular interactions necessary for FabG4 inhibition, laying the groundwork for future optimization and experimental validation of these promising compounds.

Zitieren

APA

Singh, J., Virdi, V., Sharma, R., & Verma, D. K. (2026). In silico Identification of Phytochemical Inhibitors targeting 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase (FabG4) in Mycobacterium tuberculosis. Research Journal of Biotechnology, 6(21), 89. https://doi.org/10.25303/216rjbt0890102

Vancouver

Singh J, Virdi V, Sharma R, Verma DK. In silico Identification of Phytochemical Inhibitors targeting 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase (FabG4) in Mycobacterium tuberculosis. Research Journal of Biotechnology. 2026;6(21):89. doi:10.25303/216rjbt0890102

BibTeX
@article{Singh2026,
  author = {Singh, Jagriti and Virdi, Vinny and Sharma, Rolee and Verma, Dipesh Kumar},
  title = {In silico Identification of Phytochemical Inhibitors targeting 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase (FabG4) in Mycobacterium tuberculosis},
  journal = {Research Journal of Biotechnology},
  year = {2026},
  volume = {6},
  number = {21},
  pages = {89},
  doi = {10.25303/216rjbt0890102}
}
Kostenlos starten →